Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Treatment With Gauze Soaked With Cold Magnesium Sulfate Solution Against Gauze Soaked With Cold Water for Treatment of Perineal Swelling Following Vaginal Delivery - A Double Blind Placebo Controlled Trial
Brief Summary: The purpose of this study is to compare the impact of treatment with cooled magnesium sulfate and cold water-soaked pads on perineal pain and swelling following vaginal delivery.

Assessment of appropriateness for each patient to take part in the study will be performed approximately 2 hours following delivery. Those patients who consent to participate in the trial will be allocated to treatment groups in a double-blinded, randomized manner. Women in the study group will receive treatment with pads soaked in a cold aqueous solution of magnesium sulfate at 33% (w/v) concentration, while those in the control group will receive treatment with pads soaked in cold water.

Nurses will initiate treatment according to the group to which the patient was randomized. Said pads will be given the patients routinely 5 times a day at regular times.

A physician will assess the perineal swelling according to visual (photographed) scale in which severe, moderate, light and no swelling will be defined. Measurement of swelling in centimeters (maximal length and breadth); photography, by a medical photographer or the examining doctor, of the perineal area with a centimeter ruler, before, during and after treatment (photography is dependent on patient approval and is not a precondition to participation in the trial.); and additional examination, on the above basis, will be performed regarding hemorrhoids in the event that a patient has complained of such.

A nurse will assess the perineal pain and swelling on a scale ranging from 0 to 10 prior to the patient being given the pad and an hour following treatment. An additional assessment by the same method will be performed regarding hemorrhoid pain. Any analgesia administered will also be recorded.

Likewise, for follow-up purposes a blood test for serum magnesium concentration will be taken before and after treatment.

Period of follow-up will be 48-72 hours from childbirth.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Battlefield Auricular Acupuncture; Type: EXPERIMENTAL; Interventions: Device: Battlefield Auricular Acupuncture | Intervention Type: DEVICE; Name: Battlefield Auricular Acupuncture; Assigned to Arm(s): Battlefield Auricular Acupuncture
B: Arm Label: Morphine; Type: EXPERIMENTAL; Interventions: Drug: Preservative Free Morphine | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Intervention Type: DRUG; Name: Preservative Free Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline
C: Arm Label: Magnesium sulfate; Type: ACTIVE_COMPARATOR; Interventions: Other: Cold pads soaked in Magnesium sulfate solution | Arm Label: Water; Type: SHAM_COMPARATOR; Interventions: Other: Cold pads soaked in water | Intervention Type: OTHER; Name: Cold pads soaked in Magnesium sulfate solution; Assigned to Arm(s): Magnesium sulfate | Intervention Type: OTHER; Name: Cold pads soaked in water; Assigned to Arm(s): Water
D: Arm Label: Post-partum primi and multiparous women; Type: EXPERIMENTAL; Interventions: Device: Leboride | Arm Label: Post-partum women that have already begun breast feeding; Type: EXPERIMENTAL; Interventions: Device: Leboride | Intervention Type: DEVICE; Name: Leboride; Assigned to Arm(s): Post-partum primi and multiparous women, Post-partum women that have already begun breast feeding

Answer: C